MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Gan to kagaku ryoho. Cancer & chemotherapy · 2022

[Effect of Biweekly-DCF Neoadjuvant Chemotherapy on Skeletal Muscle Mass of Esophageal Cancer Patients].

Sato Yuta, Tanaka Yoshihiro, Imai Takeharu, Ojio Hidenori, Mase Junichi, Hatanaka Yuji, Suetsugu Tomonari, Fujii Hironori, Okumura Naoki, Matsuhashi Nobuhisa, Takahashi Takao, Yoshida Kazuhiro

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Several studies reported that skeletal muscle mass affects the clinical response and quality of life of cancer patients during chemotherapy. Here we examined the adverse events and effects of anticancer drugs on the skeletal muscle mass of patients with esophageal cancer who received biweekly docetaxel, cisplatin, and 5-fluorouracil(DCF)neoadjuvant chemotherapy in our department.

SUBJECTS AND

METHODS

We retrospectively analyzed 105 patients with esophageal cancer who received biweekly-DCF neoadjuvant chemotherapy in 2009-2019. The cross-sectional area of the psoas muscle at the level of the third lumbar vertebra on computed tomography was assessed to calculate the psoas muscle index(PMI). Patients were divided into the high PMI group(high-group)and low PMI group(low-group)by cut-off value(male: 6.36 cm2/m2; female: 3.92 cm2/m2). Hematological toxicity, non-hematological toxicity, and therapeutic effect were retrospectively examined.

RESULTS

Male in the high-group had significantly less ≥Grade 3 hematological toxicity than those in the low-group. Univariate and multivariate analyses showed that PMI(odds ratio: 1, p<0.05)was significantly related to decreased hematological toxicity.

CONCLUSION

In preoperative chemotherapy for esophageal cancer, the incidence of hematological toxicity was significantly higher in patients with low skeletal muscle mass. Thus, skeletal muscle mass may be a marker for determining optimal anticancer drug dosage.

Для цитирования: Sato Yuta, Tanaka Yoshihiro, Imai Takeharu, Ojio Hidenori, Mase Junichi, Hatanaka Yuji, Suetsugu Tomonari, Fujii Hironori, Okumura Naoki, Matsuhashi Nobuhisa, Takahashi Takao, Yoshida Kazuhiro. [Effect of Biweekly-DCF Neoadjuvant Chemotherapy on Skeletal Muscle Mass of Esophageal Cancer Patients].. Gan to kagaku ryoho. Cancer & chemotherapy. 2022.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.